Thus, compared to that from lean BC carriers, the breast tissue from obese women with BC contains elevated levels of aromatase, a key enzyme in estrogen biosynthesis [29], possibly compromising the therapeutic effects of hormone therapy [30]. This evidence concerns the gene CYP19A1 and breast cancer.